✦ LIBER ✦

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

✍ Scribed by A. Purohit; V. Niederberger; M. Kronqvist; F. Horak; R. Grönneberg; R. Suck; B. Weber; H. Fiebig; M. Van Hage; G. Pauli; R. Valenta; O. Cromwell

Book ID: 108688284
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 498 KB
Volume: 38
Category: Article
ISSN: 0954-7894
DOI: 10.1111/j.1365-2222.2008.03042.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccines for birch pollen allergy based

Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1

✍ V. Mahler; S. Vrtala; O. Kuss; T. L. Diepgen; R. Suck; O. Cromwell; H. Fiebig; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Prevention of allergen-specific IgE prod

Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen

✍ Romana Hochreiter; Tatjana Stepanoska; Fatima Ferreira; Rudolf Valenta; Susanne 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Poor association between allergen-specif

Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to FcɛRI

✍ A. Purohit; S. Laffer; C. Metz-Favre; A. Verot; F. Kricek; R. Valenta; G. Pauli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB